Program | 4th European Training Symposium (ETS)

The 4th European Training Symposium (ETS) on Advanced Heart Failure Therapies offers a concise, practice-oriented program covering patient selection, mechanical circulatory support, heart transplantation, and emerging therapies. Over three days, participants will benefit from state-of-the-art lectures and hands-on sessions supported by industry partners, gaining practical experience with current and upcoming technologies.

The program is tailored for young cardiologists and cardiac surgeons seeking focused education, technical training, and the latest insights in advanced heart failure care.

Thursday, June 18, 2026

Pre-Lunch-Symposium

-> Modern advances in cardiovascular medication

Opening

Session I – Magnitude of the challenge

-> Why is Heart Failure underestimated?
-> Morbidity and Mortality of Heart Failure
-> The Concept of “Heart Cancer”
-> What does the next generation think?

Session II – Key issues of Advanced Heart Failure

-> Kidney Failure
-> Frailty
-> INTERMACS criteria
-> “I need help”

Session III – Distinguished special lecture

-> Using non-coding RNA to develop new drugs

Friday, June 19, 2026

Session IV – Right Heart and pulmonary hypertension

-> Mechanisms of RV failure
-> HF and devices: Early and late Right Heart Failure
-> Pulmonary hypertension

Session V – Advanced HF Management

-> Optimal Drug therapy
-> CRT-update
-> Edge-to-edge valve repair
-> ICD-update (inkl. WCD)
-> Baroreflex Activation Therapy

Lunch symposium: Amyloidosis – Advanced HF in HFpEF

-> Pathophysiology & epidemiology of amyloidosis
-> Imaging of amyloidosis
-> Treatment of amyloidosis

Session VI – MCS: How to manage nowadays (1)

-> Update MCS therapy
-> Anticoagulation
-> Hemodynamics
-> Infections in MCS patients

Session VII – Heart transplantation: What clinicians should know about Immunology

-> Translational Research in Transplantation
-> How foreign or self is differentiated by the immune system
-> CD3-antibodies (Teplizumab for T1D)
-> How can we avoid rejection
-> Celltherapy & personalized immunosuppression

Session VIII – The future of cardiovascular medicine

-> Micro-Robotics in Medicine
-> AI – influence on heart medicine

Saturday, June 20, 2026

Session IX – MCS: How to manage nowadays (2)

-> Aiming for Recovery
-> Gastrointestinal side effects: how to treat
-> Neurological complications
-> Pediatric VADs

Session X – Acute HF and cardiogenic shock

-> Acute HF and Shock
-> Drugs in Acute HF
-> ECMO
-> Impella / ECMELLA

Lunch symposium

tbd

Session XI – Recent Advances in Cardiomyopathies and Myocarditis

-> Diagnostics of myocarditis
-> Giant cell myocarditis
-> Peripartum Cardiomyopathy
-> Non-compaction cardiomyopathy: does it exist?

Session XII – The Future

-> MCS – New technologies in engineering
-> Engineering challenges for MCS
-> Newest VAD technology
-> TAH
-> iPS cells – a silver lining on the horizon?
-> Xenotransplantation – where do we stand right now?